Cargando…
Calculation of a First-In-Man Dose of 7-O-Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs
7-O-Succinyl macrolactin A (SMA) exerts several pharmacological effects including anti-bacterial, anti-inflammation, and anti-cancer activities. Recently, SMA has been extensively evaluated as an anti-cancer drug. Thus, the objectives of the present study were to characterise the pharmacokinetics of...
Autores principales: | Noh, Keumhan, Kang, Wonku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685435/ https://www.ncbi.nlm.nih.gov/pubmed/28274094 http://dx.doi.org/10.4062/biomolther.2016.192 |
Ejemplares similares
-
Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma
por: Jin, Jun, et al.
Publicado: (2017) -
The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt
por: Regmi, Sushil C., et al.
Publicado: (2015) -
Pharmacokinetics of Shikimic Acid Following Intragastric and Intravenous Administrations in Rats
por: Noh, Keumhan, et al.
Publicado: (2020) -
Allometric scaling in-vitro
por: Ahluwalia, Arti
Publicado: (2017) -
Pharmacokinetics of panduratin A following oral administration of a Boesenbergia pandurata extract to rats
por: Won, Jihyun, et al.
Publicado: (2021)